Regulation & law · 11/09/2001Updated: 10/17/2026 · 1 min read
National Institutes of Health to Grant Exclusive License for Escherichia Coli O157 Vaccine
Summary
The National Institutes of Health is considering granting an exclusive license to Fort Dodge Animal Health for a vaccine against Escherichia Coli O157 infection, which is composed of detoxified LPS conjugated to proteins, as described in a US patent application filed in 2001.
Original source language: Federal Register — All DocumentsOpen original release →